Multigene editing: current approaches and beyond

Brief Bioinform. 2021 Sep 2;22(5):bbaa396. doi: 10.1093/bib/bbaa396.

Abstract

CRISPR/Cas9 multigene editing is an active and widely studied topic in the fields of biomedicine and biology. It involves a simultaneous participation of multiple single-guide RNAs (sgRNAs) to edit multiple target genes in a way that each gene is edited by one of these sgRNAs. There are possibly numerous sgRNA candidates capable of on-target editing on each of these genes with various efficiencies. Meanwhile, each of these sgRNA candidates may cause unwanted off-target editing at many other genes. Therefore, selection optimization of these multiple sgRNAs is demanded so as to minimize the number of sgRNAs and thus reduce the collective negative effects caused by the off-target editing. This survey reviews wet-laboratory approaches to the implementation of multigene editing and their needs of computational tools for better design. We found that though off-target editing is unavoidable during the gene editing, those disfavored cuttings by some target genes' sgRNAs can potentially become on-target editing sites for some other genes of interests. This off-to-on role conversion is beneficial to optimize the sgRNA selection in multigene editing. We present a preference cutting score to assess those beneficial off-target cutting sites, which have a few mismatches with their host genes' on-target editing sites. These potential sgRNAs can be prioritized for recommendation via ranking their on-target average cutting efficiency, the total off-target site number and their average preference cutting score. We also present case studies on cancer-associated genes to demonstrate tremendous usefulness of the new method.

Keywords: CRISPR/Cas9; multigene editing; off-target editing; preference cutting score.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • BRCA1 Protein / genetics
  • BRCA1 Protein / metabolism
  • BRCA2 Protein / genetics
  • BRCA2 Protein / metabolism
  • Bacteria / genetics
  • Bacteria / metabolism
  • CRISPR-Cas Systems*
  • Disease Models, Animal
  • Gene Editing / methods*
  • Humans
  • Multigene Family
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism
  • Neoplasms / genetics*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neurofibromin 1 / genetics
  • Neurofibromin 1 / metabolism
  • PTEN Phosphohydrolase / genetics
  • PTEN Phosphohydrolase / metabolism
  • Plants / genetics
  • Plants / metabolism
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • RNA, Guide, CRISPR-Cas Systems / genetics*
  • RNA, Guide, CRISPR-Cas Systems / metabolism
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • NF1 protein, human
  • Neoplasm Proteins
  • Neurofibromin 1
  • Protein Isoforms
  • RNA, Guide, CRISPR-Cas Systems
  • Repressor Proteins
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • synovial sarcoma X breakpoint proteins
  • PTEN Phosphohydrolase
  • PTEN protein, human